Is there interest of Mexican adults in being prepared should they develop Alzheimer’s or other dementia?
##plugins.themes.bootstrap3.article.main##
Abstract
Objective. To explore some expectations, wishes and preferences in a sample of mature adults should they develop Alzheimer or other dementia.
Method. We surveyed 368 mature Mexican adults without dementia using a large survey created by the authors and used in a previous study; data were collected in some public places where mature people were invited to participate. The survey was completed from July 2019 to August 2020.
Results. Although most participants had considered they might suffer from dementia in the future, less than half had communicated their wishes to their relatives about future medical treatments in case they could no longer decide for themselves; very few had prepared a written advance directive. Most participants agreed that patients should know their initial diagnosis, mainly to be able to prepare themselves. The main reason given by those who would prefer to hide the diagnosis was to avoid suffering.
Discussion and conclusion. Our results highlight the need for health professionals to promote discussion with people about the possibility of suffering from dementia, as well as the importance of making decisions in advance, and letting their relatives know about them.
References
Álvarez-del Río, A., & Marván, M. L. (2021). Dilemas éticos ante la Posibilidad de Padecer la Enfermedad de Alzheimer u otras Demencias. Estudio Exploratorio. Gaceta Médica de México,157(4), 418-424. doi: 10.24875/gmm.20000848
Alzheimer’s Association. (2023). Lecanemab Approved for Treatment of Early Alzheimer’s Disease. Alzheimer’s Association. Retrieved from https://www.alz.org/alzheimers-dementia/treatments/lecanemab-leqembi
AMGEN. (2018). World’s Largest Alzheimer’s Survey Reveals Most Adults Believe a Cure Will be Developed in Their Lifetime. Retrieved from https://www.multivu.com/players/English/8004557-amgen-global-alzheimers-disease-awareness-survey/ (September 17, 2018)
Brewer, C. (2019). O, Let Me Not Get Alzheimer’s Sweet Heaven. Skyscraper Publications Limited.
Briggs, R., McHale, C., Fitzhenry, D., O’Neill, D., & Kennelly, S. P. (2018). Dementia, Disclosing the Diagnosis. QJM: An International Journal of Medicine, 111(4), 215-216. doi: 10.1093/qjmed/hcx181
Brinkman-Stoppelenburg, A., Evenblij, K., Pasman, H. R., van Delden, J. J., Onwuteaka-Philipsen, B. D., & van der Heide, A. (2020). Physicians’ and Public Attitudes Toward Euthanasia in People with Advanced Dementia. Journal of the American Geriatrics Society, 68(10), 2319-2328. doi: 10.1111/jgs.16692
Carpenter, B., & Dave, J. (2004). Disclosing a Dementia Diagnosis: A Review of Opinion and Practice, and a Proposed Research Agenda. The Gerontologist, 44(2), 149-158. doi: 10.1093/geront/44.2.149
Clarke, G., Fistein, E., Holland, A., Barclay, M., Theimann, P., & Barclay, S. (2017). Preferences for care towards the end of life when decision-making capacity may be impaired: A large scale cross-sectional survey of public attitudes in Great Britain and the United States. PLoS ONE, 12(4), e0172104. doi: 10.1371/journal.pone.0172104
Cohen, J., Marcoux, I., Bilsen, J., Deboosere, P., van der Wal, G., & Deliens, L. (2006). European Public Acceptance of Euthanasia: Socio-Demographic and Cultural Factors Associated with the Acceptance of Euthanasia in 33 European Countries. Social Science & Medicine, 63(3), 743-756. doi: 10.1016/j.socscimed.2006.01.026
Donnelley, P. (2014). We Fear Dementia More Than Cancer: Two Thirds of Over-50s Fear They Will Get Brain Condition. Daily Mail Online. Retrieved from https://www.dailymail.co.uk/health/article-2715049/We-fear-dementia-cancer-Two-thirds-50s-fear-brain-condition.html (August 14, 2014)
D’Hyver, C. (2018). Ética y Alzheimer. Es un Dilema. In O. Rivero-Serrano (Ed.). Reflexiones Sobre Dilemas Éticos en la Práctica Médica, Tomo I (pp. 59-72). Universidad Nacional Autónoma de México.
González-Huerta, I., Gutiérrez-Soriano, J., & Álvarez-del-Río, A. (2017). Decisiones médicas sobre el final de la vida en pacientes con enfermedad de Alzheimer. Fontamara.
Gutiérrez-Robledo, L. M., & Arrieta-Cruz, I. (2015). Demencias en México: La Necesidad de un Plan de Acción. Gaceta Médica de México, 151(5), 667-673.
Hernández, A., & Torres, S. (2017). La Necesidad de Cuidados del Paciente con Alzheimer y la Respuesta Social Organizada. In L. M. Gutiérrez-Robledo, M. C. García-Peña, P. A. Roa-Rojas, & A. Martínez-Ruiz (Eds.). La Enfermedad de Alzheimer y otras demencias, como problema nacional de salud (pp. 97-100). Intersistemas/CONACYT
Hickman, R. A., Faustin, A., & Wisniewski, T. (2016). Alzheimer Disease and Its Growing Epidemic: Risk Factors, Biomarkers, and the Urgent Need for Therapeutics. Neurologic Clinics, 34(4), 941-953. doi: 10.1016/j.ncl.2016.06.009
Hodes, R. (2023). Anouncements: NIA statement on report of lecanemab reducing cognitive decline in Alzheimer’s clinical trial. National Institute on Aging. Retrieved from https://www.nia.nih.gov/news/nia-statement-report-lecanemab-reducing-cognitive-decline-alzheimers-clinical-trial (06 Enero, 2023)
Holroyd, S., Turnbull, Q., & Wolf, A. M. (2002). What are Patients and Their Families Told About the Diagnosis of Dementia? Results of a Family Survey. International Journal of Geriatric Psychiatry, 17(3), 218-221. doi: 10.1002/gps.552
Instituto Nacional de Estadística, Geografía e Informática [INEGI]. (2020). Estadísticas a Propósito del Día Mundial de la Población (11 de Julio) Datos Nacionales. Comunicado de Prensa Num. 302/20, 9 de Julio de 2020. Retrieved from https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2020/Poblacion2020_Nal.pdf
Irish Hospice Foundation [IHF]. (2016). IHF Launch Seven Guidance Documents to Improve Palliative Care for People with Dementia. Retrieved from https://hospicefoundation.ie/other/ihf-launch-seven-guidance-documents-improve-palliative-care-people-dementia/
Lopez, R. P., Rose, K. M., Kenney, L., Sanborn, V., & Davis, J. D. (2020). Managing Shame: A Grounded Theory of How Stigma Manifests in Families Living With Dementia. Journal of the American Psychiatric Nurses Association, 26(2), 181-188. doi: 10.1177/1078390319832965
Low, L. F., McGrath, M., Swaffer, K., & Brodaty, H. (2019). Communicating a Diagnosis of Dementia: A Systematic Mixed Studies Review of Attitudes and Practices of Health Practitioners. Dementia, 18(7-8), 2856-2905. doi: 10.1177/1471301218761911
Mahieux, F., Herr, M., & Ankri, J. (2018). What Are the Preferences of Patients Attending a Memory Clinic for Disclosure of Alzheimer՚s Disease? Revue Neurologique, 174(7-8), 564-570. doi: 10.1016/j.neurol.2017.10.016
Mastwyk, M., Dow, B., Ellis, K. A., & Ames, D. (2016). Why Attend a Memory Clinic? What do Patients and Their Families Want and/or Expect? Australasian Journal on Ageing, 35(3), 220-224. doi: 10.1111/ajag.12257
Pan American Health Organization [PAHO]. (2017). Life Expectancy in the Americas Increases to 75 Years. Retrieved from https://www3.paho.org/hq/index.php?option=com_content&view=article&id=13722:life-expectancy-in-the-americas-increases-to-75-years&Itemid=1926&lang=en (September 26, 2017)
Piers, R., Albers, G., Gilissen, J., De Lepeleire, J., Steyaert, J., Van Mechelen, W., ... Van den Block, L. (2018). Advance Care Planning in Dementia: Recommendations for Healthcare Professionals. BMC Palliative Care, 17(1), 88. doi: 10.1186/s12904-018-0332-2
Porteri, C. (2018). Advance Directives as a Tool to Respect Patients’ Values and Preferences: Discussion on the Case of Alzheimer՚s Disease. BMC Medical Ethics, 19(1), 9. doi: 10.1186/s12910-018-0249-6
Reardon, S. (2023). FDA approves Alzheimer’s drug lecanemab amid safety concerns. Nature, 613(7943), 227-228. doi: 10.1038/d41586-023-00030-3
Reitz, C., & Mayeux, R. (2014). Alzheimer Disease: Epidemiology, Diagnostic Criteria, Risk Factors and Biomarkers. Biochemical Pharmacology, 88(4), 640-651. doi: 10.1016/j.bcp.2013.12.024
Steinbock, B., & Menzel, P. T. (2018). Advance Directives for Refusing Life-Sustaining Treatment in Dementia. Hasting Center Report, 48(S3). S75-S79. doi: 10.1002/hast.919
Tarawneh, R., & Holtzman, D. M. (2012). The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment. Cold Spring Harbor Perspectives in Medicine, 2(5), a006148. doi: 10.1101/cshperspect.a006148
The Lancet. (2022). Lecanemab for Alzheimer’s disease: tempering hype and hope. The Lancet, 400(10367), 1899. doi: 10.1016/S0140-6736(22)02480-1
van Wijmen, M., Pasman, R., Widdershoven, G., & Onwuteaka-Philipsen, B. (2015). Continuing or forgoing treatment at the end of life? Preferences of the general public and people with an advance directive. Journal of Medical Ethics, 41(8), 599-606. doi: 10.1136/medethics-2013-101544
Velázquez López, G. (2018). Síndromes demenciales. In J. R. de la Fuente, G. Heinze (Eds.). Salud mental y medicina psicológica (pp. 261-283). McGraw-Hill.
Volhard, T., Jessen, F., Kleineidam, L., Wolfsgruber, S., Lanzerath, D., Wagner, M., & Maier, W. (2018). Advance Directives for Future Dementia Can Be Modified by a Brief Video Presentation on Dementia Care: An Experimental Study. PloS One, 13(5), e0197229. doi: 10.1371/journal.pone.0197229
Volicer, L. (2016). Fear of Dementia. Journal of the American Medical Directors Association, 17(10), 875-878. doi: 10.1016/j.jamda.2016.06.022
Williams, N., Dunford, C., Knowles, A., & Warner, J. (2007). Public attitudes to life-sustaining treatments and euthanasia in dementia. International Journal of Geriatric Psychiatry, 22(12), 1229-1234. doi: 10.1002/gps.1819
World Health Organization [WHO]. (2021). Dementia. Retrieved from https://www.who.int/news-room/fact-sheets/detail/dementia (September 2, 2021)
Yadav, K. N., Gabler, N. B., Cooney, E., Kent, S., Kim, J., Herbst, N., … Courtright, K. R. (2017). Approximately One In Three US Adults Completes Any Type Of Advance Directive For End-Of-Life Care. Health Affairs, 36(7), 1244-1251. doi: 10.1377/hlthaff.2017.0175
Yates, J., Stanyon, M., Samra, R., & Clare, L. (2021). Challenges in Disclosing and Receiving a Diagnosis of Dementia: A Systematic Review of Practice from the Perspectives of People With Dementia, Carers, And Healthcare Professionals. International Psychogeriatrics, 33(11), 1161-1192. doi: 10.1017/S1041610221000119
